TerminatedPhase 3

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Stopped: Poor accrual

MexicoStarted 2005-11

Plain-language summary

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of Angioid Streaks * Choroidal neovascularization associated * Untreated patients or patients treated once with PDT Exclusion Criteria: * Ocular surgery excepting uncomplicated phacoemulsification * Glaucoma or any other ocular pathology

What they're measuring

BCVA

Fluoresceine Angiography

Optical Coherence Tomography

Trial details

NCT IDNCT00599820

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-11

View on ClinicalTrials.gov More Angioid Streaks trials